Rhythm Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€50.16
Performance (%)
-13.68%
Price
22.04.24
€36.60
Summary
This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -13.68%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 2.235% | 2.235% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $55.00 price target on the stock, up previously from $29.00.
Ratings data for RYTM provided by MarketBeat